Gestational Diabetes Mellitus: An Update

Main Article Content

Durairaj Rajkumar
Raja Lakshman Raj
Pandiappan Viswanathan
Santhakumar Preetha
Kumarakurubaran Dharmapuri Arumugam


Background: Gestational Diabetes Mellitus (GDM) is a type of diabetes mellitus with hyperglycemia that appears in pregnant women without a prior history of the disease due to insulin resistance, obesity, insufficient insulin production, etc. Since there are no obvious signs of GDM in the mother, screening is crucial to ensure the health of child. Numerous studies have reported that those mothers had GDM are twice the amount likely to develop type 1 diabetes before the age of 22 as a child or adolescent whose mother did not have gestational diabetes. On the other hand, the risks of both type 2 diabetes, its late complication like cardiovascular disease and other difficulties at birth, are all enhanced with GDM. The child may be at increased risk for developing obesity, type 2 diabetes, and cardiovascular disease in the future. Several treatment or management procedures are available, such as insulin therapy and changes in lifestyle. This review article provides an update on the epidemiology, pathogenesis, diagnosis, and treatment of GDM based on the recent literature.

Article Details

How to Cite
Durairaj Rajkumar, Raja Lakshman Raj, Pandiappan Viswanathan, Santhakumar Preetha, VengappanSathya, & Kumarakurubaran Dharmapuri Arumugam. (2023). Gestational Diabetes Mellitus: An Update. Journal of Coastal Life Medicine, 11(2), 1618–1624. Retrieved from


Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-281.

Metzger BE, Coustan DR (Eds.): Proceedings of the Fourth International Work-shop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21 (Suppl. 2): B1–B167, 1998.

American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2003;26(suppl.1):s103–s105.

Bahl S, Dhabhai N, Taneja S, Mittal P, Dewan R, Kaur J, Chaudhary R, Bhandari N, Chowdhury R (2022). Burden, risk factors and outcomes associated with gestational diabetes in a population-based cohort of pregnant women from North India.BMC Pregnancy and Childbirth. 2022, 32.

Khalil A, Rezende J, Akolekar R, Syngelaki A, Nicolaides KH. Maternal Racial Origin and Adverse Pregnancy Outcome: A Cohort Study. Ultrasound Obstet Gynecol. 2013;41(3):278-285.

Jenum AK, Morkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, et al. Impact of Ethnicity on Gestational Diabetes Identified With the WHO and the Modified International Association of Diabetes and Pregnancy Study Groups Criteria: A Population-Based Cohort Study. Eur J Endocrinol. 2012;166(2):317-324.

Li LJ, Huang L, Tobias DK and Zhang C. Gestational Diabetes Mellitus Among Asians –A Systematic Review From a Population Health Perspective. Front. Endocrinol. 2022;13:840331.

Kragelund Nielsen K, Andersen GS, Damm P, Andersen AN. Gestational Diabetes Risk in Migrants. A Nationwide, Register-Based Study of All Births in Denmark 2004 to 2015. J Clin Endocrinol Metab. 2020;105(3).

Janevic T, Zeitlin J, Egorova N, Balbierz A, Howell EA. The Role of Obesity in the Risk of Gestational Diabetes Among Immigrant and U.S.-Born Women in New York City. Ann Epidemiol. 2018;28(4):242–248.

Cunningham GF, Leveno K, Bloom S, Spong C, Dashe J, Hoffman B, Casey B. Diabetes Mellitus. In: Williams Obsterics. 2021; 383-388.

Akhalya K, Sreelatha S, Rajeshwari, Shruthi K. A review article- gestational diabetes mellitus. Endocrinol Metab Int J. 2019;7(1):26‒39.

Di Cianni G., Miccoli R., Volpe L., Lencioni C., Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab. Res. Rev. 2003;19:259–270.

Catalano P.M., Tyzbir E.D., Roman N.M., Amini S.B., Sims E.A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am. J. Obstet. Gynecol. 1991;165:1667–1672.

Phelps R.L., Metzger B.E., Freinkel N. Carbohydrate metabolism in pregnancy: XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am. J. Obstet. Gynecol. 1981;140:730–736.

Parsons J.A., Brelje T.C., Sorenson R.L. Adaptation of islets of Langerhans to pregnancy: Increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology. 1992;130:1459–1466.

Ryan EA, O’Sullivan MJ, Skyler JS. Insulin Action During Pregnancy: Studies with the Euglycemic Clamp Technique. Diabetes. 1985;34:380–389.

Plows JF, Stanley JL, Baker PN, Reynolds CM, VickersMH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018;19(11):3342-3363.

Durnwald C. Gestational diabetes: Linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin. Perinatol. 2015;39:254–258.

Zhang C, Tobias DK, Chavarro JE, Bao W, Wang D, Ley SH, Hu FB. Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. BMJ. 2014;349:g5450.

Anghebem-Oliveira MI, Martins BR, Alberton D, de RamosEAS, PichethG, de Rego, FGM. Type 2 diabetes-associated genetic variants of FTO, LEPR, PPARg, and TCF7L2 in gestational diabetes in a Brazilian population. Arch. Endocrinol. Metabol. 2017;61:238–248.

LaoTT, Ho LF, Chan BCP, Leung WC. Maternal Age and Prevalence of Gestational Diabetes Mellitus. Diabetes Care 2006:29:948–949.

PettittDJ, Jovanovic L. Low Birth Weight as a Risk Factor for Gestational Diabetes, Diabetes, and Impaired Glucose Tolerance During Pregnancy. Diabetes Care. 2007;30: S47–S149.

Levy A, Wiznitzer A, Holcberg G, Mazor M, SheinerE. Family history of diabetes mellitus as an independent risk factor for macrosomia and cesarean delivery. J. Matern. Fetal Neonatal Med. 2010;23:148–152.

Bowers K, Tobias DK, Yeung E, Hu FB, Zhang CA. Prospective study of prepregnancy dietary fat intake and risk of gestational diabetes. Am. J. Clin. Nutr. 2012; 95:446–453.

Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 2004;21;103–113.

Benhalima K, Hanssens M, Devlieger R, Verhaeghe J, Mathieu C. Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the Carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes. Int. J. Endocrinol. 2013, 2013, 248121.

Werner EF, Pettfer CM, Zuckerwise L, ReelM, FunaiEF, HendersonJ, Thung SF. Screening for gestational diabetes mellitus: Are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012;35:529–535.

Williams CB, Iqbal S, Zawacki CM, Yu D, Brown MB, HermanWH. Effect of selective screening for gestational diabetes. Diabetes Care. 1999;22:418–421.

Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study in PregnantWomen (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 2005; 352:2477–2486.

Landon MB, Spong CY, Thom E, CarpenterMW, RaminSM, Casey B, Wapner RJ, VarnerMW, Rouse DJ, ThorpJM, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 2009;361:1339–1348.

Horvath K, Koch K, Jeitler K, Matyas, BenderR, Bastian H, LangeS, SiebenhoferA. Effects of treatment in women with gestational diabetes mellitus: Systemic review and meta-analysis. BMJ. 2010;340:c1395.

AubryEM, RaioL, Oelhafen S. Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland. Diabetes Res. Clin. Pract. 2021;175: 108830.

HillierTA, PedulaKL, Ogasawara KK, VescoKK, OshiroCES, Lubarsky SL, Van MarterJ. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening. N. Engl. J. Med. 2021;384:895–904.

Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH. Gestational diabetes and the risk of offspring obesity. Pediatrics. 1998;101:e9:1–e9:7.

Catalano PM, Farrell K, Thomas A, Houston-Presley L, Mencin P, de Mouzon SH, Amini SB. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009;90:1303–1313.

Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. Diabetes Care. 1998;21(Suppl 2):B142–B149.

Gillman MW, Oakey H, Baghurst PA, Volkmer RE, Robinson JS, Crowther CA. Effect of treatment of gestational diabetes on obesity in the next generation. Diabetes Care. 2010;33:964–968.

Bellamy L, Casas J, Hingorani A, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet. 2009;373(9677):1773–1779.

Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet. 1996;347:227–230.

Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care. 2002;25:1862–1868.

HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: Preeclampsia. Am J Obstet Gynecol. 2010;202(3):255.e251–e257.

Zhao P, Liu E, Qiao Y, Katzmarzyk PT, Chaput JP, Fogelholm M, Johnson WD, Kuriyan R, Kurpad A, Lambert EV, Maher C, Maia JAR, Matsudo V, Olds T, Onywera V, Sarmiento OL, Standage M, Tremblay MS, Tudor-Locke C, Hu G; ISCOLE Research Group. Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study. Diabetologia. 2016;59(11):2339-2348.

Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational Diabetes Mellitus-Recent Literature Review. J Clin Med. 2022;28:11(19):5736.

Nguyen L, Chan SY, Teo AK. Metformin from mother to unborn child-are there unwarranted effects? EbioMedicine. 2018;35:394–404.

Mukerji G, Feig DS. Advances in Oral Anti-Diabetes Drugs in Pregnancy. Pract. Man. Diabetes Pregnancy. 2017;15:189–201.

Lee HY, Wei D, Loeken MR. Lack of metformin effect on mouse embryo AMPK activity: Implications for metformin treatment during pregnancy. Diabetes/Metab. Res. Rev. 2014: 30:23–30.

RowanJA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 2008:358:2003–2015.

Rowan J, Rush CE, Plank LD, Lu J, ObolonkinV, Coat S, HagueWM. Metformin in gestational diabetes: The offspring follow-up (MiG TOFU): Body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res. Care 2018;6:e000456.

Zeng Y, Li M, Chen Y, Jianng L, Wang S, Mo X, Li B. The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis. Adv. Med. Sci. 2014;59:95–101.